These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6428910)

  • 1. Effect of propranolol treatment on bone mass, bone mineral content, bone remodelling, parathyroid function and vitamin D metabolism in hyperthyroidism.
    Mosekilde L; Jastrup B; Melsen F; Lund B; Lund B; Sørensen OH; Nielsen HE; Yde H
    Eur J Clin Invest; 1984 Apr; 14(2):96-102. PubMed ID: 6428910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
    Orwoll ES; Meier DE
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism.
    Mosekilde L; Melsen F
    Acta Med Scand; 1978; 204(1-2):97-102. PubMed ID: 685737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-hydroxycholecalciferol-enhanced bone maturation in the parathyroprivic state.
    Russell JE; Avioli LV
    J Clin Invest; 1975 Oct; 56(4):792-8. PubMed ID: 1159088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry.
    Mosekilde L; Melsen F
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):751-8. PubMed ID: 580521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered vitamin D metabolism and bone remodelling in patients with medullary thyroid carcinoma and hypercalcitoninemia.
    Emmertsen K; Melsen F; Mosekilde L; Lund B; Lund B; Sørensen OH; Nielsen HE; Sølling H; Hansen HH
    Metab Bone Dis Relat Res; 1982; 4(1):17-23. PubMed ID: 7121251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism.
    Jastrup B; Mosekilde L; Melsen F; Lund B; Lund B; Sørensen OH
    Metabolism; 1982 Feb; 31(2):126-32. PubMed ID: 6978987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urine.
    Mosekilde L; Christensen MS; Melsen F; Sørensen NS
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):743-50. PubMed ID: 580520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral loss during centre and home haemodialysis. Influence of vitamin D metabolites and serum parathyroid hormone.
    Rickers H; Christensen M; Christiansen C; Rødbro P
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():435-40. PubMed ID: 3991537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The parathyroid function in patients with hyperthyroidism].
    Miura R; Yumita S; Sohn HE; Furukawa Y; Sakurada T; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):892-8. PubMed ID: 6500101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
    Furlanetto RP; Castro ML; de Mesquita CH; Kasamatsu TS; Vieira JG
    Rev Paul Med; 1991; 109(2):55-60. PubMed ID: 1909454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D homeostasis, bone mineral metabolism, and seasonal affective disorder during 1 year of Antarctic residence.
    Premkumar M; Sable T; Dhanwal D; Dewan R
    Arch Osteoporos; 2013; 8():129. PubMed ID: 23475735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
    Saunders J; Hall SE; Crowther A; Sönksen PH
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):67-72. PubMed ID: 679503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G; Karter Y; Aydin S; Uzun H
    Chin J Physiol; 2003 Dec; 46(4):181-6. PubMed ID: 15074839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment.
    Lund B; Storm TL; Lund B; Melsen F; Mosekilde L; Andersen RB; Egmose C; Sørensen OH
    Clin Rheumatol; 1985 Jun; 4(2):143-9. PubMed ID: 4006384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.
    Harrower AD; Fyffe JA; Horn DB; Strong JA
    Clin Endocrinol (Oxf); 1977 Jul; 7(1):41-4. PubMed ID: 880733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.